The Rise (Rare Disease) Selling Framework - Carbone, Peter W.
14,99 €
inkl. MwSt.

Versandfertig in 1-2 Wochen
payback
7 °P sammeln
  • Broschiertes Buch

The RISE (Rare Disease) Selling Framework is meant to be disruptive! It is designed to help commercial teams identify how to inspirationally RISE and become a rare voice for rare disease patients. It is challenging oneself and not the healthcare professional. In keeping aligned with biopharmaceutical organizations' respective mission statements, industry's customer interfacing teams must always keep patients top of mind. It is an important journey, a journey of putting patients first by challenging oneself to reach beyond and become a cogent rare voice for rare disease patients. The RISE…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
The RISE (Rare Disease) Selling Framework is meant to be disruptive! It is designed to help commercial teams identify how to inspirationally RISE and become a rare voice for rare disease patients. It is challenging oneself and not the healthcare professional. In keeping aligned with biopharmaceutical organizations' respective mission statements, industry's customer interfacing teams must always keep patients top of mind. It is an important journey, a journey of putting patients first by challenging oneself to reach beyond and become a cogent rare voice for rare disease patients. The RISE Selling Framework is a transformational approach that focuses on Inspiration. It is about mustering the daily will and skill to reach beyond, because it is the patients who are fighting every day to reach beyond. They are creating Inspirational steps that lead to Inspirational stories. We must RISE every-single-day because our healthcare professionals RISE every-single-day and our patients RISE every-single-day to fight, touch others, and share their gifts. RISE, it's a new day. Are you ready to reach beyond your current skill set for rare disease patients?
Autorenporträt
Peter W. Carbone has worked in the biopharma industry since 1992 with Fortune 500 companies. His responsibilities are comprised of leadership, sales and learning & development within the biopharma sector, which include therapeutics for an array of diseases and conditions. Throughout his tenure within the industry he learned that customer interfacing within the rare disease market is different and require a shift in approach and mindset. In terms of other interests, Peter is an avid martial artist where he has earned belts in multiple disciplines. He also enjoys walking to his own beats (so to speak) - he is a drummer.